The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Poster Presentation(C) Pharmaceutical Biology

[28-63-am]Nervous System 6

Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 63 (4301, Bldg. 4, Area 4 [3F]) (7)
Discusser: Shirakawa Hisashi, Ichiro Takasaki

[28-63-am-62S]Usefulness of wheel-running behavior as a mouse model of behavioral addiction

○Saya Arakaki1, Aoi Mori1, Masabumi Minami1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)

[28-63-am-63S]Early Parkinson’s disease model mice exhibit auditory sensory attenuation

○Yu Tajika1, Masabumi Minami1, Iku Tsutsui-Kimura1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)

[28-63-am-64S]Positive allosteric modulation of adenosine A2A receptors drives antipsychotic effects in a mouse model of schizophrenia

○Hanwen Mao1, Koustav Roy1,2, Tsuyoshi Saitoh1,2,3, Michael Lazarus1,2,3 (1. Intl. Inst. Integr. Sleep Med. (WPI-IIIS), Tsukuba Univ, 2. Tsukuba Inst. Adv. Res., Tsukuba Univ., 3. Inst. Med., Tsukuba Univ.)

[28-63-am-65S]Examination of serotonin receptor subtypes for anti-allodynic effects expressed via nicotinic acetylcholine receptors in the ventral posterolateral thalamic nucleus.

○Taiki Hada1, Kai Takehara2, Tomohiro Tanaka2, Hideo Saji3, Masashi Ueda2 (1. Pharm. Sci., Okayama Univ., 2. Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ., 3. Kyoto Univ.)

[28-63-am-66S]A novel brain-spinal top-down neuronal pathway that generates and sensitizes pain

○Yohei Kurino1, Kazuki Fujimori1, Kota Tsunoda1, Kaoru Seiriki2,3, Hitoshi Hashimoto2,4,5,6,7, Makoto Tsuda1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ, 2. Grad. Sch. Pharm. Sci., Osaka Univ, 3. Inst. Integrated Res. Insitute. Science Tokyo, 4. United Grad. Sch. Child Development. Osaka Univ, 5. D3-center. Osaka Univ, 6. Inst. Open and Transdisciplinary Res. Initiatives. Osaka Univ, 7. Grad. Sch. Med., Osaka Univ)

[28-63-am-67S]Measurement of spinal dorsal horn neuronal activity in mice exposed to repeaated social defeat stress

○Momona Ikeda1, Yuka Shimizu1, Moeko Kanaya2, Daisuke Uta3, Masahiro Ohsawa1 (1. Lab Systems Pharmacol, Facult Pharmaceuticalsci, Teikyo University, 2. Division of Life Science, Graduate School of Science and Engineering, Saitama University, 3. Dept. Applied Pharm., Grad. Sch. Med and Pharm Sci., Univ. Toyama)

[28-63-am-68S]Role of Excitatory Tone in the Lateral Habenula in LPS-Induced Depressive-like Behavior in mice

○Hikaru Kumagai1, Yumi Tsuneura2, Tohru Matsuki2, Kenjiro Seki1 (1. Ohu University School of Pharmaceutical Science, Department of Pharmacology, 2. Dept. of Cellular Pathology, Inst. for Dev. Res., Aichi Dev. Disability Ctr., Kasugai, Japan)

[28-63-am-69S]Cilostazol alleviate glucocorticoid-induced brain pH decrease, depression-like behavior, and reduced hippocampal neurogenesis.

○Ramu Nishida1, Riko Masuzaki1, Ayami Kita1, Ryota Araki1, Takeshi Yabe1 (1. Setsunan University)

[28-63-am-70]Improvement of lipopolysaccharide-induced depression-like behaviors in mice by the selective Kir4.1 channel Inhibitor Lys05

○Saki Shimizu1, Akane Yoshida1, Yuto Ishizaki1, Yukihiro Ohno1 (1. Dept. Pharmacol., Fac. Pharm, Osaka Med. Pharm. Univ.)

[28-63-am-71]Chronic pain animal models enhance spontaneous glutamatergic transmission on rat spinal dorsal horn in vitro and in vivo.

○Daisuke Uta1,2, Masahito Sawahata1, Toshiaki Kume1, Megumu Yoshimura2, Kohei Koga2 (1. Grad. Sch. Med and Pharm Sci., Univ. Toyama, 2. Grad. Sch. Med Sci., Kyushu Univ)

[28-63-am-72]Reduced chewing opportunities induce emotional behavior disorders: Involvement of hippocampal TRPV1 and histamine systems

○Fukie Yaoita1, Airi Harada1, Manatsu Tsuchiya1, Misaki Gonaikawa1, Koichi Tan-No1 (1. Fac. Pharm. Sci., Tohoku Med. & Pharm. Sci. Univ.)
Back to Category List